Alkylresorcinols as a New Type of Gut Microbiota Regulators Influencing Immune Therapy Efficiency in Lung Cancer Treatment

Figure 7

Correlations between AR content in serum and faeces and cell-mediated immunity parameters in patients with lung cancer before and after ICI therapy with different dynamics.

(a) Positive dynamics

(b) Non-negative dynamics

(c) Negative dynamics